#10 Elsa Bernard: IPSS-M in MDS

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/0c/68/f6/0c68f694-4619-b07b-514f-f1f24381ecf4/mza_11527742438603350550.jpg/600x600bb.jpg

Trainee Pearls

The EBMT Trainee Committee

16 episodes

2 days ago

Welcome to “Trainee Pearls”, a new initiative brought to you by the EBMT Trainee Committee to deliver the most important messages (“the pearls”) of high-profile research works in hematology and bone marrow transplant to our fellow trainees all over the world. The topics will span from classical hematology to more focused bone marrow transplant research. The selected research article will be discussed directly with young authors who have been involved with the published work.

Medicine

Health & Fitness

RSS

All content for Trainee Pearls is the property of The EBMT Trainee Committee and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/19621461/19621461-1637602937949-a7c1eda9a2c1c.jpg

#10 Elsa Bernard: IPSS-M in MDS

Trainee Pearls

28 minutes 33 seconds

3 years ago

#10 Elsa Bernard: IPSS-M in MDS

Risk stratification and therapeutic decision-making for myelodysplastic syndromes (MDS) are based on the International Prognostic Scoring System–Revised (IPSS-R), which considers hematologic parameters and cytogenetic abnormalities. Somatic gene mutations are not yet used in the risk stratification of patients with MDS. Combining genomic profiling with hematologic and cytogenetic parameters, the IPSS-M improves the risk stratification of patients with MDS and represents a valuable tool for clinical decision-making.

CONNECT WITH US

https://twitter.com/TheEBMT_Trainee

https://www.ebmt.org/trainee-committee

https://twitter.com/CarmeloGurnari